Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

Mostrar otras versiones (1)

New therapeutic targets are a valuable resource in the struggle to reduce the morbidity and mortality associated with the COVID-19 pandemic, caused by the SARS-CoV-2 virus. Genome-wide association studies (GWAS) have identified risk loci, but some loci are associated with co-morbidities and are not...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Tobias, Odon, Valerie, Harvey, Calum, Collins, Mark O, Peden, Andrew, Franklin, John, Graves, Emily, Marshall, Jack N.G., Souza, Cleide dos Santos, Zhang, Sai, Azzouz, Mimoun, Gordon, David, Krogan, Nevan, Ferraiuolo, Laura, Snyder, Michael P, Shaw, Pamela J, Rehwinkel, Jan, Cooper-Knock, Johnathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923113/
https://www.ncbi.nlm.nih.gov/pubmed/35291294
http://dx.doi.org/10.1101/2022.03.06.483172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923113/
https://www.ncbi.nlm.nih.gov/pubmed/35291294
http://dx.doi.org/10.1101/2022.03.06.483172

Ejemplares similares